LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)
2011

LZAP Inhibits p38 MAPK Phosphorylation and Activity

publication Evidence: moderate

Author Information

Author(s): An Hanbing, Lu Xinyuan, Liu Dan, Yarbrough Wendell G.

Primary Institution: Vanderbilt University

Hypothesis

LZAP acts as a tumor suppressor by inhibiting p38 MAPK activity.

Conclusion

LZAP inhibits p38 MAPK phosphorylation and activity, potentially through increased association with the Wip1 phosphatase.

Supporting Evidence

  • LZAP expression is lost in a subset of human head and neck squamous cell carcinoma.
  • Loss of LZAP enhances tumor growth and angiogenesis in xenograft models.
  • LZAP inhibits p38 phosphorylation in a dose-dependent manner.
  • Depletion of LZAP increases p38 phosphorylation in various cell types.

Takeaway

LZAP is a protein that helps stop cancer cells from growing by blocking a signal called p38 MAPK. When LZAP is missing, the cancer cells can grow faster.

Methodology

The study involved co-immunoprecipitation and immunoblotting to analyze the interaction between LZAP and p38 MAPK in various cell lines.

Limitations

The study primarily focuses on in vitro experiments, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0016427

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication